• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌患者的生活质量问题:系统评价。

Quality of life issues in patients with ductal carcinoma in situ: a systematic review.

机构信息

Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Department of Clinical Oncology, Tuen Mun Hospital, Hospital Authority, Tuen Mun, Hong Kong.

出版信息

Support Care Cancer. 2024 Oct 1;32(10):695. doi: 10.1007/s00520-024-08864-x.

DOI:10.1007/s00520-024-08864-x
PMID:39352516
Abstract

PURPOSE

Ductal carcinoma in situ (DCIS) of the breast is one of the most common pre-invasive cancers diagnosed in women. Quality of life (QoL) is extremely important to assess in studies including these patients due to the favorable prognosis of the disease. The primary objective of this systematic review was to compile a comprehensive list of QoL issues, all existing QoL assessment tools, and patient-reported outcome measures used to assess DCIS.

METHODS

A search was conducted on Ovid MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases from inception to August 2023, using keywords such as "ductal carcinoma in-situ", "quality of life", and "patient-reported outcomes." QoL issues and QoL tools in primary research studies were extracted.

RESULTS

A total of 67 articles identified issues pertaining to patients with DCIS spanning physical, functional, and psychosocial QoL domains. Physical and functional issues observed in patients included pain, fatigue, and impaired sexual functioning. Psychosocial issues such as anxiety, depression, and confusion about one's disease were also common. QoL tools included those that assessed general QoL, breast cancer-specific tools, and issue-specific questionnaires.

CONCLUSION

The current instruments available to assess QoL in patients with DCIS do not comprehensively capture the issues that are pertinent to patients. Thus, the modification of existing tools or the creation of a DCIS-specific QoL tool is recommended to ensure that future research will be sensitive towards challenges faced by patients with DCIS.

摘要

目的

乳腺导管原位癌(DCIS)是女性最常见的一种前浸润性癌。由于该疾病的预后良好,在包括这些患者的研究中,评估生活质量(QoL)极其重要。本系统评价的主要目的是综合列出与 DCIS 相关的 QoL 问题、所有现有的 QoL 评估工具以及用于评估 DCIS 的患者报告结局测量。

方法

从 Ovid MEDLINE、EMBASE 和 Cochrane 对照试验中心注册数据库中检索从开始到 2023 年 8 月的文献,使用的关键词包括“导管原位癌”、“生活质量”和“患者报告的结果”。从原始研究中提取与 DCIS 患者相关的 QoL 问题和 QoL 工具。

结果

共确定了 67 篇文章,这些文章涵盖了患者的身体、功能和社会心理 QoL 领域的问题。患者中观察到的身体和功能问题包括疼痛、疲劳和性功能障碍。焦虑、抑郁和对疾病的困惑等心理社会问题也很常见。QoL 工具包括评估一般 QoL 的工具、乳腺癌专用工具和特定问题的问卷。

结论

目前用于评估 DCIS 患者 QoL 的工具不能全面捕捉与患者相关的问题。因此,建议修改现有的工具或创建 DCIS 特异性 QoL 工具,以确保未来的研究能够敏感地关注 DCIS 患者面临的挑战。

相似文献

1
Quality of life issues in patients with ductal carcinoma in situ: a systematic review.导管原位癌患者的生活质量问题:系统评价。
Support Care Cancer. 2024 Oct 1;32(10):695. doi: 10.1007/s00520-024-08864-x.
2
What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?原位导管癌(DCIS)女性在做出治疗决策时认为哪些生活质量问题至关重要?
Breast Cancer. 2017 Sep;24(5):720-729. doi: 10.1007/s12282-017-0765-0. Epub 2017 Feb 28.
3
Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.导管原位癌诊断后与健康相关的生活质量趋势。
J Clin Oncol. 2016 Apr 20;34(12):1323-9. doi: 10.1200/JCO.2015.62.7281. Epub 2016 Feb 16.
4
Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network.与大型综合健康网络中导管原位癌 (DCIS) 治疗模式和患者报告结果相关的因素。
Breast Cancer Res Treat. 2023 Feb;197(3):683-692. doi: 10.1007/s10549-022-06831-w. Epub 2022 Dec 17.
5
Severe fatigue after treatment of ductal carcinoma in situ: A comparison with age-matched breast cancer survivors and healthy controls.导管原位癌治疗后的严重疲劳:与年龄匹配的乳腺癌幸存者及健康对照的比较。
Breast. 2017 Feb;31:76-81. doi: 10.1016/j.breast.2016.10.020. Epub 2016 Nov 4.
6
Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls.随时间推移诊断为导管原位癌、早期浸润性乳腺癌的女性与年龄匹配对照者的生活质量。
Breast Cancer Res Treat. 2012 Jul;134(1):379-91. doi: 10.1007/s10549-012-2048-y. Epub 2012 Apr 8.
7
Patient-reported outcomes in ductal carcinoma in situ: A systematic review.导管原位癌患者报告结局的系统评价。
Eur J Cancer. 2017 Jan;71:95-108. doi: 10.1016/j.ejca.2016.09.035. Epub 2016 Dec 15.
8
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.导管原位癌女性的风险认知与心理社会结局:一项队列研究的纵向结果
J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12.
9
Psychological morbidity in women diagnosed with ductal carcinoma in situ compared with women with early breast cancer receiving radiotherapy.乳腺导管原位癌患者与接受放疗的早期乳腺癌患者的心理发病率比较。
Support Care Cancer. 2020 May;28(5):2247-2254. doi: 10.1007/s00520-019-05034-2. Epub 2019 Aug 26.
10
Identifying opportunities to support patient-centred care for ductal carcinoma in situ: qualitative interviews with clinicians.识别支持导管原位癌患者为中心的护理机会:对临床医生的定性访谈。
BMC Cancer. 2020 Apr 30;20(1):364. doi: 10.1186/s12885-020-06821-5.

引用本文的文献

1
Comparative Analyses of Van Nuys Prognostic Index and NCCN Guidelines in Ductal Carcinoma Treatment in a Brazilian Hospital.巴西一家医院中导管癌治疗的范奈斯预后指数与美国国立综合癌症网络(NCCN)指南的比较分析
Life (Basel). 2025 Mar 9;15(3):432. doi: 10.3390/life15030432.
2
Labels, Language, and Other Strategies to Improve Communication About Lower Grade Forms of Ductal Carcinoma In Situ of the Breast: A National Delphi Survey.标签、语言及其他改善乳腺导管原位癌低级别形式相关沟通的策略:一项全国性德尔菲调查
Int J Breast Cancer. 2025 Feb 17;2025:8642832. doi: 10.1155/ijbc/8642832. eCollection 2025.
3
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial.

本文引用的文献

1
Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial.主动监测与低危 DCIS 治疗:LORD 试验中的女性偏好。
Eur J Cancer. 2023 Oct;192:113276. doi: 10.1016/j.ejca.2023.113276. Epub 2023 Aug 4.
2
The long-term psychosocial consequences of screen-detected ductal carcinoma in situ and invasive breast cancer.屏幕检测出的导管原位癌和浸润性乳腺癌的长期心理社会后果。
Breast. 2023 Aug;70:41-48. doi: 10.1016/j.breast.2023.06.003. Epub 2023 Jun 7.
3
Outcomes of DCIS treated with breast conserving surgery without radiotherapy on recurrence, survival, and health-related quality of life.
低风险导管原位癌患者报告的结局:COMET随机临床试验的二次分析
JAMA Oncol. 2025 Mar 1;11(3):300-309. doi: 10.1001/jamaoncol.2024.6556.
保乳手术而未接受放疗治疗 DCIS 的复发、生存和健康相关生活质量的结果。
ANZ J Surg. 2023 Sep;93(9):2208-2213. doi: 10.1111/ans.18459. Epub 2023 Apr 16.
4
Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network.与大型综合健康网络中导管原位癌 (DCIS) 治疗模式和患者报告结果相关的因素。
Breast Cancer Res Treat. 2023 Feb;197(3):683-692. doi: 10.1007/s10549-022-06831-w. Epub 2022 Dec 17.
5
Factors Associated With Cosmetic Outcomes After Treatment With a Novel Form of Breast Intraoperative Radiation Therapy.新型乳房术中放射治疗后美容效果的相关因素。
J Surg Res. 2023 Mar;283:514-522. doi: 10.1016/j.jss.2022.10.077. Epub 2022 Nov 24.
6
Oncoplastic Breast Surgery versus Conservative Mastectomy in the Management of Large Ductal Carcinoma In Situ (DCIS): Surgical, Oncological, and Patient-Reported Outcomes.保乳整形手术与保乳根治术治疗乳腺导管原位癌(DCIS)的疗效比较:手术、肿瘤学及患者报告结局
Cancers (Basel). 2022 Nov 16;14(22):5624. doi: 10.3390/cancers14225624.
7
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).乳腺磁共振成像后导管原位癌手术偏好与接受情况的相关性:ECOG-ACRIN 癌症研究组(E4112)的辅助研究。
JAMA Netw Open. 2022 May 2;5(5):e2210331. doi: 10.1001/jamanetworkopen.2022.10331.
8
"Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.“这是癌症吗?” 对导管原位癌诊断和治疗相关的幸存者关注点的定性探索。
Cancer. 2022 Apr 15;128(8):1676-1683. doi: 10.1002/cncr.34126. Epub 2022 Feb 22.
9
Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).患者报告的乳腺磁共振成像检测负担在导管原位癌女性中的研究:ECOG-ACRIN 癌症研究组(E4112)的辅助研究。
JAMA Netw Open. 2021 Nov 1;4(11):e2129697. doi: 10.1001/jamanetworkopen.2021.29697.
10
Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35.毒性指数、患者报告结局与 NRG 肿瘤学/NSABP B-35 用于降低乳腺癌风险的内分泌治疗的早期停药
J Clin Oncol. 2021 Dec 1;39(34):3800-3812. doi: 10.1200/JCO.21.00910. Epub 2021 Sep 23.